ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Microplegia Versus Cardioplexol® in Coronary Artery Bypass Surgery With Minimal Extracorporeal Circulation: Comparison of Two Cardioplegia Concepts
Friday, April 10, 2020
Submitted by
Source
Source Name: The Thoracic and Cardiovascular Surgeon
In this small series of propensity score matched patients, two methods of administering cardioplegia, each using a different agent, were assessed for outcomes of isolated CABG. A repeated infusion with Basel Microplegia was superior to a single shot of Cardioplexol® for troponin release, creatinine kinase, and ICU stay. Major adverse events did not differ.